ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,271Medicare Part D Prescriptions Filled, Including Refills

Rank: 54 out of 252

$835K Total Retail Price of All Prescriptions

Rank: 26 out of 252

394 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 394 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 394 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 9,089 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 532 359 1 2
HYDROCODONE-ACETAMINOPHEN 464 256 S3 2 5
FUROSEMIDE 450 327 3 7
LEVOTHYROXINE SODIUM 420 343 4 1
LISINOPRIL 304 200 5 3
OMEPRAZOLE 297 231 6 6
METFORMIN HCL 259 120 7 9
GABAPENTIN 254 194 8 11
ZOLPIDEM TARTRATE 236 134 9 21
POTASSIUM CHLORIDE 235 176 10 8
AMLODIPINE BESYLATE 230 141 11 4
ATORVASTATIN CALCIUM 217 156 12 16
CITALOPRAM HBR 216 185 13 15
WARFARIN SODIUM 190 152 14 14
NEXIUM 180 105 15 23
CARVEDILOL 176 138 16 22
SPIRONOLACTONE 147 119 17 53
GLIPIZIDE ER 147 94 17 90
SERTRALINE HCL 146 119 19 27
TAMSULOSIN HCL 141 129 20 26
CLOPIDOGREL 132 101 21 29
TRAMADOL HCL 132 117 21 17
DIVALPROEX SODIUM 122 71 23 113
HYDROCHLOROTHIAZIDE 121 73 24 13
DONEPEZIL HCL 121 121 24 28
METOPROLOL TARTRATE 120 82 26 10
KLOR-CON M20 116 70 27 69
MELOXICAM 111 62 28 20
CLONIDINE HCL 99 33 29 35
PLAVIX 99 71 29 43
PREDNISONE 99 71 29 42
RISPERIDONE 97 70 32 81
LYRICA 94 65 33 66
QUETIAPINE FUMARATE 89 63 34 77
NAMENDA 86 86 35 41
ATENOLOL 86 34 35 18
ALLOPURINOL 86 49 35 30
CRESTOR 82 72 38 34
GLIPIZIDE 81 44 39 52
VENLAFAXINE HCL ER 79 62 40 105
ACTOS 78 65 41 135
MIRTAZAPINE 75 61 42 58
SINGULAIR 74 45 43 100
FLUTICASONE PROPIONATE 73 54 44 36
TRAZODONE HCL 70 49 45 31
CARBIDOPA-LEVODOPA 69 63 46 107
LOSARTAN-HYDROCHLOROTHIAZIDE 68 54 47 49
FENTANYL 68 28 S2 47 126
ISOSORBIDE MONONITRATE ER 67 58 49 50
METOPROLOL SUCCINATE 67 52 49 19
TRICOR 66 47 51 145
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 45 52 25
SEROQUEL 64 46 53 149
SUCRALFATE 63 36 54 125
CELEBREX 62 53 55 101
PANTOPRAZOLE SODIUM 62 47 55 62
PHENYTOIN SODIUM EXTENDED 60 54 57 103
ESCITALOPRAM OXALATE 56 17 58 56
BENICAR HCT 54 47 59 210
LOSARTAN POTASSIUM 53 40 60 24
JANUVIA 53 15 60 88
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 40 62 87
ALENDRONATE SODIUM 52 48 62 32
NOVOLIN R 51 21 64 190
SYNTHROID 50 24 65 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 28, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.